This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vexxon, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: **Yean-Hee Park: Innovating Protein Production**
Introduction
Yean-Hee Park is a notable inventor based in Seoul, Korea, who has contributed significantly to the field of biotechnology. With one patent to his name, he has developed an innovative method for producing soluble and active recombinant proteins. His work leverages advanced techniques to tackle common challenges in protein expression and solubility.
Latest Patents
Yean-Hee Park's patent, titled "Method for preparing soluble and active recombinant proteins using PDI as a fusion partner," details a novel approach to enhance the production of recombinant proteins. This method involves utilizing a modified protein disulfide isomerase (PDI) as a fusion partner to increase the expression rate and improve the solubility and folding of the expressed target protein. The implications of this invention are profound, particularly for the development of pharmaceutical proteins and industrial applications, as it addresses issues related to low yield and solubility that are often encountered with traditional fusion partners.
Career Highlights
Currently, Yean-Hee Park is associated with Vexxon, Inc., where he applies his expertise in biotechnology to advance the field. His innovative methodologies in protein preparation are paving the way for improvements in how recombinant proteins are produced and utilized in various industries.
Collaborations
Throughout his career, Yean-Hee Park has worked alongside esteemed colleagues such as Hang-Cheol Shin and Hyang-Do Song. Their collaborative efforts have contributed to the successful development of his patented methods and have fostered a culture of innovation at Vexxon, Inc.
Conclusion
Yean-Hee Park stands out as a key figure in biotechnological innovation, particularly in the realm of protein production. His patent not only showcases his inventiveness but also promises to enhance the efficiency and effectiveness of recombinant protein applications in the pharmaceutical industry and beyond. As he continues his work at Vexxon, Inc., the potential for further advancements in this field remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile